And We Have the New Taken Away

I went in for my first treatment today with the new drug, Alimta, and also fully expected the begin with the clinical trial of drug of MKC-1. However, I was told that I am not eligible for MKC-1 because the previous treatment was working and the only reason I am going to a Stage Two treatment is that the carboplatin and the Taxol were too toxic and were causing numbness in my hands and feet. The MKC-1 clinical trial is limited to those people who did not improve with their Stage one treatment. Sounds a bit strange to me. I would think that they would want to know if improving patients can gain even more improvement with their new drug. However, I also realize that clinical trials have very specific purposes and they usually only deal with one issue at a time so that the results don't get confused. However, the Alimta is supposed to be very effective on its own so we are hoping that it will be the case and that our improvement will continue. I did have my first treatment with Alimta and so far I feel fine. The side effects usually show up on the second day so I'll let you know how I feel in a day or two.